Earnings Scheduled For July 29, 2021
Companies Reporting Before The Bell
• Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
Analyzing OPKO Health’s Unusual Options Activity
OPKO Health (NASDAQ:OPK) shares experienced unusual options activity on Thursday. The stock price moved up to $3.56 following the option alert.
OPKO’s BioReference Laboratories Announces COVID-19 Testing Program For Royal Caribbean Group
MIAMI, June 22, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal
OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China
OPKO Health Inc’s (NASDAQ:OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in patients with stage 3/4…
Ladenburg Thalmann Initiates Coverage On OPKO Health with Buy Rating, Announces Price Target of $7
Ladenburg Thalmann analyst Jeffrey Cohen initiates coverage on OPKO Health (NASDAQ:OPK) with a Buy rating and announces Price Target of $7.
OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics
OPKO Health Inc’s (NASDAQ:OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics…
OPKO Health Announces SaleOf iIs Sterile Fill And Finish Manufacturing Facility In Ireland To Horizon Therapeutics For $65M
OPKO Health, Inc. (NASDAQ:OPK) announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in Waterford, Ireland to Horizon Therapeutics plc
Cramer Shares His Thoughts On MP Materials, Nokia And More In ‘Lightning Round’
On CNBC's "Mad Money Lightning Round," Jim Cramer said he would pass on Opko Health Inc. (NASDAQ: OPK).